Get started
Novavax, Inc.Novavax, Inc.Novavax, Inc.

Novavax, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsForecastSeasonalsBondsETFs

NVAX trade ideas

NVAX - Big PictureNVAX has been making lower lows since 1998, and price is currently falling towards the descending angle. (orange circles) Will it touch it again? If price falls below $3 it will. Looking at the big picture, every time NVAX touched this declining trend line, price went parabolic. How high could price go? Look at the purple channel. Price either peaked at the bottom or the top of the parallel channel. (white circles) It took about six months to three years to go from the bottom of the descending angle to its blow off top. And it saw gains between 10 - 70X. Where would price retrace to after the blow off top? Look at the yellow parallel channel. Price retraced to the top of the channel, and eventually fell into this channel, bouncing within this range. Prices could never find support on the bottom of the channel, and broke below, falling to the descending angle and creating another lower low. The only exception was in 2012, where price was able to break back out of the channel and reached a blow off top in 2015. Watch the 21 EMA. (blue moving average) If price bounces off the descending angle, in the future watch when it breaks above the 21 EMA. If price can find support on top of the 21 EMA, it should carry price to its blow off top. Does a touch of the descending angle guarantee a bounce up to its blow off top in the purple channel? No. But looking at the history of NVAX, it has done this 4 times since 1998. Could price touch the descending angle, and fall way lower? Sure can. $3.54 is NVAXs all time low. Breaking below this price, which it would if it touched the descending angle, would mean there's no support left to prevent price from falling to the pennies. I'm not saying this would happen, but it's possible, especially when price enters unchartered all time lows.
NASDAQ:NVAXLong
by babychester
8
NVAX Looking BearishThis is a split screen of NVAX, both on the weekly time frame. The chart on the right is the bollinger bands. Currently there's a squeeze and the mouth is just beginning to open. Price is under the white basis line, and if the mouth of the bands begins to open wider, it's likely price will get dragged down and ride the bottom yellow band. The chart on the left is a line chart with oscillators. Price has been trading within a range since February of 2023. (Yellow parallel channel) It's been bouncing between the $6.35 and $9.50 level. If price breaks below the $6.35 level, it would then test $5.00 as support. (Orange dashed line) Looking at both the rsi and stochastics, strength and momentum are falling, and are in bearish territory. So there's a chance price could break below the parallel channel. Couple this with the opening of the bollinger bands, and NVAX looks very bearish.
NASDAQ:NVAXLong
by babychester
4
NOVAVAX we can waitHello investors, we are all looking for the chance to manage our money ourselves and make high profits. I would like to make my own contribution to this. Here is my trade from NOVAVAX. My idea invest 100 eur or usd and get almost 900% profit. Buying and holding is currently the best option. Basically, I advise everyone who follows my recommendations, but also others, to find out about market trends, companies and, above all, future prospects. In the future, I will publish 2 trend positions from the areas of stocks, commodities and cryptocurrencies for review every week. Have fun and good luck
NASDAQ:NVAXLong
by WhaleWaveSurfer
4
$NVAX Novavax, Inc. Long term PT 360 and higherNASDAQ:NVAX Novavax, Inc. Long term PT 360 and higher Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NASDAQ:NVAXLong
by BADQOMOCAWGOWLD
NVAX Novavax Options Ahead of EarningsIf you haven`t bought NVAX during the Covid Pandemic: Then analyzing the options chain and the chart patterns of NVAX Novavax prior to the earnings report this week, I would consider purchasing the 7.50usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $0.87. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NASDAQ:NVAXLong
by TopgOptions
4
NVAX Novavax Vaccine approved! Buy Opportunity!If you haven`t bought NVAX during the pandemic: Then you need to know that NVAX Novavax's recent achievements in gaining full marketing authorization for its COVID-19 vaccine, Nuvaxovid, in the UK and Singapore, alongside its availability in major U.S. pharmacies, have ignited optimism among investors. These milestones signify a bright future for NVAT stock. The international authorization of Nuvaxovid opens doors to vast markets, enhancing revenue potential and global recognition for Novavax. the EU delayed the approval, but will update its decision by the end of this month. Nuvaxovid's availability at CVS and Rite Aid in the U.S. immediately after regulatory clearance demonstrates its acceptance and accessibility. Nuvaxovid is a protein-based COVID-19 vaccine, different from the mRNA vaccines of PFE and MRNA. My price target is $10 by the end of this month. Looking forward to read your opinion about it.
NASDAQ:NVAXLong
by TopgOptions
$NVAX Trending Back Down to the Buy ZoneNVAX has started distributing millions of COVID-19 vaccine shots. However, NVAX is trending back down towards the buy zone. I think that this will present a great second chance buy opportunity after NVAX's recent rally to $8. The markets have been affected by the new Israel Palestine conflict. Other key events this week are September PPI inflation data and Fed meeting minutes on Wednesday October 11. I think the markets are likely to have some sideways price action on Tuesday in anticipation of the new inflation and fed data.
NASDAQ:NVAXLong
by realchartchamp
2
Covid & Vaccine Related Novavax Long Play in the cardsHi guys! So lately theres been some buzz on a particular variant, increased cases of hospitalizations and government backing. At risk population that require vaccinations/ boosters will always exist. Therefore, i believe this fact along with various technical analysis findings can make companies such as Biontech, Moderna and even not as famous Novavax potential plays. (Look below for my analysis on Biontech) Jumping right in. This is a technical analysis on Novavax (NVAX) on the 3 day timeframe. Zoomed in we can see that we have a GOLDEN CROSS. Between the: 21 EMA 50 SMA Being on the 3 Day its ALOT more Powerful than having it on 1 Day and it may influence the larger timeframes. Which is what we want. We have also maintained SUPPORT on both Moving Average. (21 EMA and 50 SMA) This is a great sign, if we continue like how we are with our current candle during the close that would further confirm Support and a bullish case in my opinion. This 3 day candle will close on the 8th of September. Pay attention to how big the body of candle gets on the close. With this i would like Volume to start to pick up especially if and when we get to the "flat trendline". Another important development to notice is the Ascending Triangle. This can be giving us evidence we are in the process of BOTTOMING out. Watch for the breakout ABOVE the Flatline. This with confirmation of Support on flatline would be a Major Area to take Long Positions. I would ADVISE AGAINST buying inside the triangle. But Belowthe Ascending Support Line would be an area for Stop losses. Watch also how the MACD acts. If we continue in Green and the Blue/Orange lines make it ABOVE 0 level. We will be off to the races, as it would be the necessary catalyst that provides momentum to have the triangle play out. __________________________________________________________________________________ Thank you for taking the time to read my analysis. Hope it helped keep you informed. Please do support my ideas by boosting, following me and commenting. Thanks again. Stay tuned for more updates on NVAX in the near future. If you have any questions, do reach out. Thank you again. DISCLAIMER: This is not financial advice, i am not a financial advisor. The thoughts expressed in the posts are my opinion and for educational purposes. Do not use my ideas for the basis of your trading strategy, make sure to work out your own strategy and when trading always spend majority of your time on risk management strategy.
NASDAQ:NVAXLong
by SafofAllTrades
2
$NVAX Key Price Targets After 10%+ Intraday RallyNVAX has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX's COVID vaccine for patient ages 12+, and the European Union is set to make a decision in October. I believe that NVAX has promising short-term outlook that will lead to a rally with a break above $9. So far $9.18 has been a key resistance target, but I believe that NVAX will ultimately break out to the light blue resistance level at $16.21
NASDAQ:NVAXLong
by realchartchamp
1
Novavax (NVAX) Imminent Breakout from this Accumulation RangeI started an Investment Gems series with hopes of finding the best long-term investment opportunities in the bear market. NVAX was by far my favorite investment opportunity because I see a clear path for NVAX to climb from $6-7 price levels to $288. As discussed in my previous analysis, NVAX has reached this $288 price target 3 times in the past and I believe that there will be a fourth time. My previous analysis can be found here: Current Accumulation Range At the end of May I began posting NVAX as an investment gem with a buy zone between $6.50 and $7 (the two yellow lines). Bullish news came out, in which NVAX was given a $350 million payout for unused COVID vaccines that resulted in a quick 55% pump to the orange trendline ($9.18) We have been trading NVAX along this accumulation range by selling above the $9.18 orange trendline and buying in the buy zone between $6.50 and $7. These buy and sell opportunities are marked with red and green arrows. NVAX is currently trending towards the buy zone for another buy opportunity. However, I think that NVAX is likely to breakout from this accumulation phase within the next few weeks or months. I would be cautious of getting shaken out by selling at $9.18 and NVAX ends up trending up higher towards the long-term $288 price target. For me NVAX is a long-term play to $288.
NASDAQ:NVAXLong
by realchartchamp
NVAX Long Term Investment to $288AX buy range was between $6.50 and $7. I was also willing to DCA down to $5.50. After entering the buy zone, bullish news came out and NVAX had a 55% pump to $10. $8 was acting as a local support level and NVAX is showing continued bullishness for now. This is a long term hold for me (3-5 years with a long term price target around $288) Target Price TP 1 $10 is the first key price target TP 2 $23 is the second key price target I can add more price targets later, but I will be holding until $288.
NASDAQ:NVAXLong
by realchartchamp
2
Will Novavax NVAX go higher? SHORTNVAX popped today for a price jump of more than 20%. Canada agreed to pay out on a contract for COVID vaccines it now does not want in the amount of $350M. This is hardly enough to the fundamentals of the company overall. So the question arises, have traders and / or investors overreacted to a one time bonus which is essentially revenue without overhead and expense. My opinion is that this is an overreaction and that the price will drop after the pop hits a high. Buying long right now is essentially the risk of buying a high that will not go higher. On the Chris Moody dual RSI indicator, the longer one hour TM in black is over 75 while the shorter 5 minute TM in blue has peaked and dropped from 95 to 60. This is in essence bearish divergence. The other indicator, the mass index, shows the value arriving at the reversal zone where a drop to below 26.5 will be the trigger. Overall, for both fundamental and technical reasons, I will enter a short trade on NVAX expecting a correction / pullback from the pop the stock got after a one-time bonus of a payout for not producing unneeded vaccines.
NASDAQ:NVAXShort
by AwesomeAvani
1
Can NVAX rise again?NVAX has had significant down trending over a wide range of time. On the 4H chart it seems to be pivoting from a swing bottom 3-4 days ago. This is accompanied by a cross of the MACD lines under the histogram on that indicator and a flip of volatility on the relative volatility indicator. NVAX has been subject to significant short selling. Price is presently nearly two standard deviations below the mean anchored VWAP set in mid May. Basically it is in deep undervalued oversold territory and now with a rise. The volume profile has a point of control level considerably above the mean VWAP. This is the level with the highest volume of trades showing most trades occurred well above VWAP. This would be traders taking profit and selling or alternatively short sellers opening a position but more likely a combination of them. Price wants to ascend to at least VWAP if not the POC line. My analysis is that any significant rise could begin a squeeze on short positions. Those closing with a buy to cover trade would in effect be synergizing new buyers and add to the bullish momentum, Accordingly, I will open a position early and see if I can get in ahead of a potential short squeeze. While speculative, a narrow stop loss at 6.80 the second band line below the mean VWAP will take a lot of risk off the trade and allow me to be patient comfortably watching the price action.
NASDAQ:NVAXLong
by AwesomeAvani
8